PLXPQ — PLx Pharma Winddown Share News
0.000.00%
Last trade - 00:00- $0.00m
- -$9.82m
- $8.21m
PLx Pharma Inc expected to post a loss of 56 cents a share - Earnings Preview
PLx Pharma Inc reports results for the quarter ended in March - Earnings Summary
Brief: Plx Pharma Posts Q1 Adjusted Loss Per Share $0.66
PLx Pharma Inc expected to post a loss of 72 cents a share - Earnings Preview
Protalix up on positive data from genetic disorder therapy study
PLx Pharma Inc reports results for the quarter ended in December - Earnings Summary
Brief: PLx Pharma Reports Q4 GAAP Loss Per Share Of $0.73
PLx Pharma Inc expected to post a loss of 71 cents a share - Earnings Preview
Brief: PLx Pharma Names Janet Barth Vice President, Investor Relations & Corporate Communications
U.S. STOCKS ON THE MOVE-Lordstown, Team Inc, F45 Training
U.S. STOCKS ON THE MOVE-Acutus Medical, Team Inc, Hyzon Motors
PLx Pharma Inc reports results for the quarter ended in September - Earnings Summary
U.S. STOCKS ON THE MOVE-Blink Charging, Lordstown, Acutus Medical
PLx Pharma up on strong aspirin sales, smaller-than-expected Q3 loss
Brief: PLx Pharma Inc Reports Third Quarter 2021 Results And Provides Business Update
PLx Pharma Inc expected to post a loss of 46 cents a share - Earnings Preview
Brief: PLX Pharma Says Supplied Vazalore To 30,000+ Stores Nationwide, E-Commerce Sites
Brief: PLx Pharma Issues Statement On Recent USPTF Recommendations On Aspirin Therapy For Primary Prevention Of Cardiovascular Disease
PLx Pharma Inc reports results for the quarter ended in June - Earnings Summary